Loading organizations...
Loading organizations...
Biotechnology company developing immunotherapy and antibody therapeutics.
Eutilex has raised $18.1M across 1 funding round.
Eutilex has raised $18.1M in total across 1 funding round.
Eutilex has raised $18.1M in total across 1 funding round.
Eutilex's investors include DS Asset Management, G.N. Tech Venture Capital, Kolon Investment, SNU Bio Angel.
Eutilex has raised $18.1M across 1 funding round. Most recently, it raised $18.1M Series A in December 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 8, 2016 | $18.1M Series A | DS Asset Management, G.N. Tech Venture Capital, Kolon Investment, SNU Bio Angel |